Found 119 Enz. Inhib. hit(s) with all data for entry = 7973 TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 130nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 180nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 190nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 200nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 250nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 330nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 340nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 380nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 440nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 450nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 450nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 590nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 730nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 780nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 810nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 820nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 820nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 840nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 930nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 950nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.04E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.30E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.53E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.60E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.60E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.90E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 1.98E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.21E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.26E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.40E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.44E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.50E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.50E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.74E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.80E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 2.90E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 3.13E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 3.70E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 4.00E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 4.20E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 4.30E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 5.75E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 5.77E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 6.35E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 6.40E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Sanofi
US Patent
Sanofi
US Patent
Affinity DataIC50: 6.60E+3nMpH: 7.5Assay Description:The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ...More data for this Ligand-Target Pair
